Statistical breathing curve sampling to quantify interplay effects of moving lung tumors in a 4D Monte Carlo dose calculation framework.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 29 12 2021
revised: 28 05 2022
accepted: 27 07 2022
pubmed: 22 8 2022
medline: 9 9 2022
entrez: 21 8 2022
Statut: ppublish

Résumé

The interplay between respiratory tumor motion and dose application by intensity modulated radiotherapy (IMRT) techniques can potentially lead to undesirable and non-intuitive deviations from the planned dose distribution. We developed a 4D Monte Carlo (MC) dose recalculation framework featuring statistical breathing curve sampling, to precisely simulate the dose distribution for moving target volumes aiming at a comprehensive assessment of interplay effects. We implemented a dose accumulation tool that enables dose recalculations of arbitrary breathing curves including the actual breathing curve of the patient. This MC dose recalculation framework is based on linac log-files, facilitating a high temporal resolution up to 0.1 s. By statistical analysis of 128 different breathing curves, interplay susceptibility of different treatment parameters was evaluated for an exemplary patient case. To facilitate prospective clinical application in the treatment planning stage, in which patient breathing curves or linac log-files are not available, we derived a log-file free version with breathing curves generated by a random walk approach. Interplay was quantified by standard deviations σ in D Interplay induced dose deviations for single fractions were observed and evaluated for IMRT and volumetric arc therapy (σ It is feasible to combine statistically sampled breathing curves with MC dose calculations. The universality of the presented framework allows comprehensive assessment of interplay effects in retrospective and prospective clinically relevant scenarios.

Identifiants

pubmed: 35988480
pii: S1120-1797(22)02020-8
doi: 10.1016/j.ejmp.2022.07.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-111

Informations de copyright

Copyright © 2022 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Asmus von Münchow (A)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Katrin Straub (K)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Christoph Losert (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Roel Shpani (R)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Jan Hofmaier (J)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Philipp Freislederer (P)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Christian Heinz (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Christian Thieke (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Matthias Söhn (M)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Markus Alber (M)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.

Ralf Floca (R)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Division of Medical Image Computing, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.

Claus Belka (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Munich, Germany; Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Germany.

Katia Parodi (K)

Department of Experimental Physics - Medical Physics, Faculty of Physics, LMU Munich, Munich, Germany.

Michael Reiner (M)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Florian Kamp (F)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany. Electronic address: florian.kamp@uk-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH